Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
Genetic Classification Model Differentiates MDS Stem, Progenitor Cells from Healthy Bone Marrow
FDA Grants Breakthrough Therapy Designation to Sacituzumab Govitecan for Second-Line Treatment of ES-SCLC
Genetic Study Uncovers Potential Therapy-Actionable Transcription Factors in MDS